Merck & Co., Inc. (NYSE:MRK):
-0-
TO: Pharmaceutical Analysts, Reporters and Editors
WHAT: Merck & Co., Inc. will host a conference call for
pharmaceutical analysts and journalists to discuss the
APPROVe study of VIOXX.
WHO: Peter S. Kim, Ph.D., president, Merck Research
Laboratories
Kenneth C. Frazier, senior vice president and general
counsel, Merck
Raymond P. Bain, vice president, Biostatistics and
Research Decision Sciences, Merck Research Laboratories
WHEN: Tuesday, May 30, 2006, 4:45 p.m. ET
DIAL-IN: In the United States, dial (800) 561-2813/ Passcode:
82833258
Outside of the United States, dial (617) 614-3529/
Passcode: 82833258
REPLAY: A replay of this call will be available from 6:45 p.m. ET,
May 30 until 11:59 p.m. ET, June 13.
In the United States, dial (888) 286-8010/ Passcode:
92540523
Outside of the United States, dial (617) 801-6888/
Passcode: 92540523
WEBCAST: A live audio Web cast will be available at:
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=190190
&eventID=1326501 (Due to its length, this URL may need to be
copied/pasted into your Internet browser's address field. Remove the
extra space if one exists).
© 2006 Business Wire
